The FDA has approved the use of Letairis (ambrisentan), from Gilead Sciences, in combination with Adcirca (tadalafil) for the treatment...
Actelion Ltd announced the formal acceptance of the New Drug Application (NDA) for selexipag (Uptravi) by the FDA. The NDA...